57409-51-5

Basic information

• Product Name: 2,4-DIOXO-4-THIOPHEN-2-YL-BUTYRIC ACID METHYL ESTER
• Synonyms: SALOR-INT L499307-1EA;IFLAB-BB F1673-1679;ART-CHEM-BB B016256;METHYL 2,4-DIOXO-4-(THIEN-2-YL)-4-YLBUTANOATE;METHYL 2,4-DIOXO-4-THIEN-2-YLBUTANOATE;METHYL 2,4-DIOXO-4-(THIOPHEN-2-YL)BUTANOATE;AKOS BBS-00001177;AKOS B016256
• CAS NO: 57409-51-5
• Molecular Formula: C9H8O4S
• Molecular Weight: 212.22
• Mol File: 57409-51-5.mol
• Article Data: 6

Chemical Properties

• Melting Point: 87.0 to 91.0 °C
• Boiling Point: 366.1°Cat760mmHg
• Flash Point: 120℃
• Appearance: /Solid
• Density: 1.06
• Vapor Pressure: 1.5E-05mmHg at 25°C
• Refractive Index: 1.539
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 5.89±0.46(Predicted)
• CAS DataBase Reference: 2,4-DIOXO-4-THIOPHEN-2-YL-BUTYRIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-DIOXO-4-THIOPHEN-2-YL-BUTYRIC ACID METHYL ESTER(57409-51-5)
• EPA Substance Registry System: 2,4-DIOXO-4-THIOPHEN-2-YL-BUTYRIC ACID METHYL ESTER(57409-51-5)

Safety Data

• Hazard Codes: Xi,F
• Statements: 36/37/38-43
• Safety Statements: 26-36/37/39
• HazardClass: IRRITANT
• Hazardous Substances Data: 57409-51-5(Hazardous Substances Data)

Usage

Chemical Properties

Yellow solid

InChI:InChI=1/C9H8O4S/c1-13-9(12)7(11)5-6(10)8-3-2-4-14-8/h2-4H,5H2,1H3

Upstream product

• 553-90-2 Dimethyl oxalate 
• 88-15-3 2-Acetylthiophene 
• 124-41-4 sodium methylate 
• 95-92-1 oxalic acid diethyl ester 

Downstream Products

• 182415-24-3 3-(2-thienyl)-1H-pyrazole-5-carboxylic acid 
• 194491-44-6 [5-(2-thienyl)isoxazol-3-yl]methanol 
• 615270-33-2 C₂₃H₂₈N₂O₄S 
• 517870-23-4 5-(2-thienyl)-3-isoxazolecarboxylic acid methyl ester 
• 947097-11-2 methyl 4-[5-oxo-8-(2-thienyl)-4,5,6,9-tetrahydrotetrazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-9-yl]benzoate 
• 947122-27-2 9-(4-isopropylphenyl)-8-(2-thienyl)-4,9-dihydrotetrazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5(6H)-one 
• 947122-31-8 9-(2,4-dimethoxyphenyl)-8-(2-thienyl)-4,9-dihydrotetrazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5(6H)-one 
• 947969-80-4 9-(2,5-dimethoxyphenyl)-8-(2-thienyl)-4,9-dihydrotetrazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5(6H)-one 
• 947097-08-7 9-(3,4-dimethoxyphenyl)-8-(2-thienyl)-4,9-dihydrotetrazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5(6H)-one 
• 947122-35-2 9-(4-hydroxy-3-methoxyphenyl)-8-(2-thienyl)-4,9-dihydrotetrazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5(6H)-one 
• 947097-15-6 9-(2,4-dichlorophenyl)-8-(2-thienyl)-4,9-dihydrotetrazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5(6H)-one 
• 947969-92-8 9-(4-hydroxyphenyl)-8-(2-thienyl)-4,9-dihydrotetrazolo[1',5':1,2]pyrimido[4,5-d]pyridazin-5(6H)-one 

Relevant articles and documents

Design, synthesis, biological evaluation and in silico studies of pyrazole‐based nh2‐acyl oseltamivir analogues as potent neuraminidase inhibitors

Oseltamivir represents one of the most successful neuraminidase (NA) inhibitors in the current anti‐influenza therapy. The 150‐cavity of NA was identified as an additional binding pocket, and novel NA inhibitors have been designed to occupy the 150‐cavity

CYCLIC SULFAMIDE COMPOUNDS FOR TREATMENT OF HBV

The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful for disruption of HBV core protein assembly, and methods of treating Hepatitis B (HBV) infection.

CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME

The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful as modulators of Hepatitis B (HBV) core protein, and methods of treating Hepatitis B (HBV) infection.